| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank , DGIDB | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
1.18 | approved | agonist |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | alpha adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | beta adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | beta adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | beta adrenergic receptor | small molecule | NA | drugbank | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
NA | approved | agonist |
| mephentermine | dopamine d2 receptor | NA | Successful target | TTD , DGIDB | Systemic arterial pressure[MeSHID:D062186] Maintenance[MeSHID:D008283] Blood Pressure[MeSHID:D001794] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] |
0.18 | approved | unknown |
| click here to return to the previous page | ||||||||